NextCell Pharma AB
STO:NXTCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NextCell Pharma AB
STO:NXTCL
|
SE |
|
Izumi Co Ltd
TSE:8273
|
JP |
|
Hornbach Baumarkt AG
LSE:0ENN
|
DE |
|
Raytheon Technologies Corp
NYSE:RTX
|
US |
|
Bausch + Lomb Corp
NYSE:BLCO
|
CA |
|
Wesfarmers Ltd
ASX:WES
|
AU |
|
United Labels AG
XETRA:ULC
|
DE |
Wall St Price Targets
NXTCL Price Targets Summary
NextCell Pharma AB
According to Wall Street analysts, the average 1-year price target for NXTCL is 3.57 SEK with a low forecast of 3.54 SEK and a high forecast of 3.68 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NXTCL's stock price target?
Price Target
3.57
SEK
According to Wall Street analysts, the average 1-year price target for NXTCL is 3.57 SEK with a low forecast of 3.54 SEK and a high forecast of 3.68 SEK.